The decisions made at the NENC Medicines Subcommittee June 2023 meeting can now be found at: https://ntag.nhs.uk/meetings/decision-summaries/
This includes the recommendations made by NTAG in May 2023 meeting and NICE Technology appraisals from the 1st February 2023 to 31st March 2023.
The following guidelines/position statements were approved and can be found at:
- NENC Decision Aid for DOACs for Atrial Fibrillation – review date extended for further 12 months. https://ntag.nhs.uk/recommendations/cardiovascular-system-recommendations/
- NENC regional guidance on type 2 diabetes https://ntag.nhs.uk/recommendations/endocrine-system-recommendations/
- NENC Dronedarone shared care guideline https://ntag.nhs.uk/recommendations/cardiovascular-system-recommendations/
- NENC Sativex® shared care guideline for the treatment of spasticity in multiple sclerosis https://ntag.nhs.uk/recommendations/central-nervous-system-recommendations/
- NENC Commmissioning policy for Baricitinib for patients hospitalised due to COVID-19 (adults and children aged 2 years and over) https://ntag.nhs.uk/recommendations/miscellaneous-recommendations/
- NENC Penicillin Allergy Assessment Oral Challenge and De-labelling Secondary Care https://ntag.nhs.uk/recommendations/miscellaneous-recommendations/